Cancer News and Research

Latest Cancer News and Research

Drinking tea thrice a week is linked with longer, healthier life

Drinking tea at least three times a week is linked with a longer and healthier life, according to a study published today in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC).

9 Jan 2020

Study: State-mandated notifications on mammogram reports are not worded effectively

A new study suggests that state-mandated notifications on mammogram reports intended to inform women of the health risks related to breast density are not worded effectively.

9 Jan 2020

PCORI announces new research funding opportunities to improve patient-centered outcomes

Following congressional reauthorization of its funding in December 2019, the Patient-Centered Outcomes Research Institute (PCORI) began accepting new proposals for research designed to help patients and those who care for them to weigh their options and make better-informed healthcare decisions.

9 Jan 2020

Study reveals cellular cross-talk between regulatory T cells and fibroblast cells in pancreatic cancer microenvironment

A multidisciplinary Michigan Medicine team is shedding new light on the role of regulatory T cells in pancreatic cancer - and, in mouse models, have uncovered a new potential target to improve immunotherapy approaches to the deadly disease.

9 Jan 2020

New initiative encourages female medical students to specialize in orthopedics

Women now account for more than half of all medical students in the United States. However, orthopaedic surgery struggles to attract women to the field.

9 Jan 2020

Prostate cancer deaths are on the rise, shows new ACS report

Despite most cancers seeing a drop in deaths, prostate cancer deaths are on the rise in the U.S. New reporting from the American Cancer Society shows that in 2020, the number of men who will die from prostate cancer will hit a record high over the last two decades, with an increase of 5 percent since just last year.

9 Jan 2020

“Hotspotting” programs have virtually no impact on patient outcomes, indicates study

The new health care practice of "hotspotting" -- in which providers identify very high-cost patients and attempt to reduce their medical spending while improving care -- has virtually no impact on patient outcomes, according to a new study led by MIT economists.

9 Jan 2020

Researchers identify synergistic cellular pathways that considerably amplify lifespan

Scientists at the MDI Biological Laboratory, in collaboration with scientists from the Buck Institute for Research on Aging in Novato, Calif., and Nanjing University in China, have identified synergistic cellular pathways for longevity that amplify lifespan fivefold in C. elegans, a nematode worm used as a model in aging research.

9 Jan 2020

Pathios appoints Stuart Hughes as CEO and announces US$8.8M Series A financing round

Pathios Therapeutics Limited, an innovative biotech company focused on the development of first-in-class therapies for autoimmune diseases and cancer, today announced a US$8.8M Series A financing round with leading international healthcare investors Canaan and Australia’s Medical Research Commercialization Fund managed by Brandon Capital.

9 Jan 2020

Researchers identify new mechanism associated with p53 mutation

More than half of cancer cases worldwide are associated with genetic mutations in p53, the protein responsible for protecting DNA from changes that can lead to cancer.

9 Jan 2020

Loss of stress hormone is a hallmark of pancreatitis, shows study

In work that could have clinical implications, UT Southwestern researchers find that humans and mice with pancreatitis are deficient in a stress hormone called FGF21.

9 Jan 2020

SVC112 molecule acts specifically against head and neck cancer stem cells

The red, tube-shaped flowers of the firecracker bush (Bouvardia ternifolia), native to Mexico and the American Southwest, attract hummingbirds.

8 Jan 2020

CU Cancer Center named National Pancreas Foundation Center of Excellence

The most important factor predicting the survival of pancreatic cancer patients is whether the cancer can be surgically removed (whether the cancer is "resectable").

8 Jan 2020

UC Riverside research team receives NIH grant to study breast cancer

A research team led by biochemists at the University of California, Riverside, has received a four-year grant from the National Institutes of Health, or NIH, to study breast cancer -- the most common cancer in women worldwide -- and the racial disparities in the treatment of the disease.

8 Jan 2020

Researchers use single cell genome sequencing to study malaria transmission

New technology employing single cell genome sequencing of the parasite that causes malaria has yielded some surprising results and helps pave the way for possible new intervention strategies for this deadly infectious disease, according to Texas Biomedical Research Institute Assistant Professor Ian Cheeseman, Ph.D. Dr. Cheeseman was Principal Investigator of a three-year study published in the January 2020 edition of Cell Host & Microbe, a high-impact peer-reviewed publication.

8 Jan 2020

Exercising when sick can help you feel better, says Penn State Health physician

The winter cold and flu season may try to knock out your new year's plans to get or stay healthy, but the good news is you can fight back.

8 Jan 2020

Cystic fibrosis carriers have higher risk for all CF-related conditions

Conventional wisdom says that having just one mutated copy of the cystic fibrosis gene has no effects on a person's health--the disease occurs when both copies of the gene are mutated. But a new study from the University of Iowa suggests that may not be the case.

8 Jan 2020

Scientists discover how dying cells prevent dangerous immune reactions

Dying cells in the body can keep the immune system in check, thus preventing unwanted immune responses against the body's own tissues.

8 Jan 2020

Research adds definitive evidence about how the body's earliest immune cells are formed

One day the advance could lead to a patient's own skin cells being used to produce new cells for cancer immunotherapy or to test autoimmune disease interventions.

8 Jan 2020

Two-drug combination could be effective against malignant mesothelioma

Exposure to asbestos is the major risk factor for malignant mesothelioma, a type of aggressive cancer that mostly affects the pleura - the tissue that lines the lungs - and the peritoneum - the tissue that lines the abdomen. This has been known for decades, yet the molecular characterisation of mesothelioma is barely known and treatment options are scarce.

8 Jan 2020